Clinical Trial Update: Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial comparing hospitalization rates in schizophrenia patients treated with oral antipsychotics versus intramuscular depot aripiprazole; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE ORAL (Aripiprazole)
• Aripiprazole depot (aripiprazole lauroxil)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2014-01-16